VTCN1 anticorps (AA 26-258) (HRP)

N° du produit ABIN1046259

Détail du produit anti-VTCN1 anticorps (HRP)

Antigène: VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))

Épitope: AA 26-258

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VTCN1 est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human V-set domain-containing T-cell activation inhibitor 1 protein (26-258AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid freeze and thaw cycles.
Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur VTCN1

Antigène: VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))

Autre désignation: VTCN1 (VTCN1 Produits)

Synonymes: anticorps B7h4, anticorps B7s1, anticorps B7x, anticorps BC032925, anticorps B7-H4, anticorps B7H4, anticorps B7S1, anticorps B7X, anticorps B7h.5, anticorps PRO1291, anticorps VCTN1, anticorps RGD1311204, anticorps V set domain containing T cell activation inhibitor 1 L homeolog, anticorps V-set domain containing T cell activation inhibitor 1, anticorps V-set domain containing T-cell activation inhibitor 1, anticorps V set domain containing T cell activation inhibitor 1, anticorps vtcn1.L, anticorps VTCN1, anticorps vtcn1, anticorps Vtcn1

Sujet:

Background: Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.

Aliases: B7 family member, H4 antibody, B7 H4 antibody, B7 homolog 4 antibody, B7 superfamily member 1 antibody, B7 superfamily, member 1 antibody, B7-H4 antibody, B7h.5 antibody, B7h4 antibody, B7S1 antibody, B7x antibody, BC032925 antibody, Immune costimulatory protein B7-H4 antibody, Immune costimulatory protein B7H4 antibody, MGC41287 antibody, PRO1291 antibody, Protein B7S1 antibody, RP11 229A19.4 antibody, T cell costimulatory molecule B7x antibody, T-cell costimulatory molecule B7x antibody, V set domain-containing T cell activation inhibitor 1 antibody, V-set domain-containing T-cell activation inhibitor 1 antibody, VCTN1 antibody, Vtcn1 antibody, VTCN1_HUMAN antibody

UniProt: Q7Z7D3